Published in Brain Behav Immun on December 01, 2012
The thrifty psychiatric phenotype. Acta Psychiatr Scand (2014) 1.97
Alterations of Mitochondrial DNA Copy Number and Telomere Length With Early Adversity and Psychopathology. Biol Psychiatry (2015) 1.10
Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev (2015) 1.05
Telomere length and cortisol reactivity in children of depressed mothers. Mol Psychiatry (2014) 1.00
Race-related health disparities and biological aging: does rate of telomere shortening differ across blacks and whites? Biol Psychol (2014) 0.98
Depression, anxiety and telomere length in young adults: evidence from the National Health and Nutrition Examination Survey. Mol Psychiatry (2014) 0.94
The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons. Psychosom Med (2016) 0.86
Phenotypic flexibility as a measure of health: the optimal nutritional stress response test. Genes Nutr (2015) 0.82
Telomerase dysregulation in the hippocampus of a rat model of depression: normalization by lithium. Int J Neuropsychopharmacol (2015) 0.81
Telomere length is associated with sleep duration but not sleep quality in adults with human immunodeficiency virus. Sleep (2014) 0.81
Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls. Psychoneuroendocrinology (2015) 0.77
Telomere length is associated with oppositional defiant behavior and maternal clinical depression in Latino preschool children. Transl Psychiatry (2015) 0.77
Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study. Transl Psychiatry (2016) 0.76
Peripheral telomere length and hippocampal volume in adolescents with major depressive disorder. Transl Psychiatry (2015) 0.75
Leukocyte telomere length and depression, anxiety and stress and adjustment disorders in primary health care patients. BMC Psychiatry (2017) 0.75
Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway. Psychoneuroendocrinology (2016) 0.75
Awareness of Prediabetes and Diabetes among Persons with Clinical Depression. Int J Endocrinol (2015) 0.75
Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia. Neuropsychiatr Dis Treat (2015) 0.75
On telomeres long and short. J Psychiatry Neurosci (2015) 0.75
The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care (2001) 15.36
Association between telomere length in blood and mortality in people aged 60 years or older. Lancet (2003) 10.56
Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol (2006) 5.28
Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia (2006) 4.71
The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun (2001) 2.89
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry (2006) 2.85
Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol (2006) 2.50
Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One (2011) 2.30
Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med (2007) 2.09
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry (2009) 2.01
Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev (2012) 1.67
Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders. Intern Med (2003) 1.64
Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety (2010) 1.58
Immune suppression and immune activation in depression. Brain Behav Immun (2010) 1.48
Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. Am J Psychiatry (1998) 1.48
Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care (2003) 1.46
Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis (2007) 1.40
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol (2008) 1.40
Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost (2009) 1.39
History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care (2005) 1.35
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull (2009) 1.32
Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatr Genet (2007) 1.31
Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med (2005) 1.30
Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat (2006) 1.27
Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord (2007) 1.19
Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res (2012) 1.16
Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs (2009) 1.06
Decreased plasma adiponectin concentration in major depression. Neurosci Lett (2006) 1.04
Immune system dysregulation in adolescent major depressive disorder. J Affect Disord (2008) 1.04
Telomere shortening & metabolic/vascular diseases. Indian J Med Res (2007) 1.02
Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol (Oxf) (2007) 1.00
Age-related deregulation of naive T cell homeostasis in elderly humans. Age (Dordr) (2010) 1.00
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry (2006) 0.99
Unrecognized glucose intolerance is not associated with depression. Screening for Impaired Glucose Tolerance study 3 (SIGT 3). Diabet Med (2008) 0.98
Differences in glucose tolerance between deficit and nondeficit schizophrenia. Schizophr Res (2008) 0.92
Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med (2007) 0.89
Neutrophilia and lymphopenia in major mood disorders. Psychiatry Res (1988) 0.89
Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. The Baltimore Longitudinal Study of Aging. J Am Geriatr Soc (1986) 0.89
Could glucose be a proaging factor? J Cell Mol Med (2008) 0.85
Depression, endocrinologically a syndrome of premature aging? Maturitas (2002) 0.84
Delineating the relationship between stress, depressive symptoms, and glucose intolerance. Diabetes Care (2000) 0.84
Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications. Expert Rev Cardiovasc Ther (2009) 0.82
Insulin tolerance test in depression. Arch Gen Psychiatry (1969) 0.81
Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment. J Psychopharmacol (2012) 0.78
Tracking the clonal origin of lethal prostate cancer. J Clin Invest (2013) 5.79
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget (2012) 3.88
Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry (2011) 3.33
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Discovery-based science education: functional genomic dissection in Drosophila by undergraduate researchers. PLoS Biol (2005) 2.33
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. Schizophr Res (2005) 2.12
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A (2011) 2.12
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry (2009) 2.01
Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70
Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci U S A (2002) 1.67
Olanzapine treatment of residual positive and negative symptoms. Am J Psychiatry (2005) 1.57
Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. Schizophr Bull (2010) 1.55
Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res (2007) 1.54
Prospective study of outcomes after reduction mammaplasty: long-term follow-up. Plast Reconstr Surg (2006) 1.53
Telomere length as a risk factor for hereditary prostate cancer. Prostate (2013) 1.50
Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology (2002) 1.46
A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients. Psychiatry Res (2011) 1.45
Telomeres: prognostic markers for solid tumors. Int J Cancer (2006) 1.44
Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics (2007) 1.44
Prognostic value of normal myocardial perfusion scintigraphy in patients with chest pain and left bundle branch block. Rev Port Cardiol (2002) 1.41
Citizen science reveals unexpected continental-scale evolutionary change in a model organism. PLoS One (2011) 1.40
Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat (2009) 1.40
A study of large-bowel volvulus in urban Australia. Can J Surg (2006) 1.38
Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale. Schizophr Res (2012) 1.37
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull (2009) 1.32
Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull (2006) 1.30
Glucose abnormalities in the siblings of people with schizophrenia. Schizophr Res (2008) 1.29
Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat (2006) 1.27
Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry (2013) 1.27
Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer (2006) 1.25
Parental history of type 2 diabetes in patients with nonaffective psychosis. Schizophr Res (2007) 1.25
Factor structure of the Brief Negative Symptom Scale. Schizophr Res (2012) 1.23
Association between cancer-free survival and telomere DNA content in prostate tumors. J Urol (2005) 1.21
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. J Clin Psychiatry (2009) 1.20
Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res (2013) 1.16
Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits? Schizophr Bull (2010) 1.11
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Developmental changes in rat cardiac titin/connectin: transitions in normal animals and in mutants with a delayed pattern of isoform transition. J Muscle Res Cell Motil (2005) 1.09
Summer birth and deficit schizophrenia: a pooled analysis from 6 countries. Arch Gen Psychiatry (2004) 1.09
Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer (2011) 1.09
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol (2012) 1.06
Recent advances in polyhydroxyalkanoate production by mixed aerobic cultures: from the substrate to the final product. Macromol Biosci (2006) 1.04
Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol (2012) 1.04
Inflammation and schizophrenia. Schizophr Bull (2013) 1.02
Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer (2012) 1.00
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull (2013) 0.98
The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms. Eur Psychiatry (2004) 0.98
Distribution of tract deficits in schizophrenia. BMC Psychiatry (2014) 0.98
Characterization of an extracellular polysaccharide produced by a Pseudomonas strain grown on glycerol. Bioresour Technol (2008) 0.98
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Mod Pathol (2009) 0.96
Deficit schizophrenia: association with serum antibodies to cytomegalovirus. Schizophr Bull (2005) 0.95
Advanced paternal age and parental history of schizophrenia. Schizophr Res (2011) 0.94
Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. Int J Cancer (2013) 0.94
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials. Neuropsychopharmacology (2002) 0.94
Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment. Neuropsychobiology (2005) 0.93
Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin. Psychiatry Res (2008) 0.93
Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis. Psychosom Med (2011) 0.92
18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 0.92
Differences in glucose tolerance between deficit and nondeficit schizophrenia. Schizophr Res (2008) 0.92
Relationship between clinical and neuropsychological characteristics in child and adolescent first degree relatives of subjects with schizophrenia. Schizophr Res (2009) 0.92
Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features. Psychiatry Res (2012) 0.91
Telomere DNA content predicts breast cancer-free survival interval. Clin Cancer Res (2007) 0.91
Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. Schizophr Res (2009) 0.91
Cannabis use and age of diagnosis of schizophrenia. Eur Psychiatry (2009) 0.91
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. Schizophr Res (2013) 0.91
Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia. Schizophr Res (2011) 0.91
Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues. Mol Cancer Res (2005) 0.90
A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA). Curr Med Res Opin (2007) 0.90
Organ-wide telomeric status in diseased and disease-free prostatic tissues. Prostate (2010) 0.90
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol (2010) 0.89
Chemiluminescent measurement of telomere DNA content in biopsies. Biotechniques (2002) 0.89
Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer. Urology (2009) 0.89
Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate (2011) 0.89
Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia. Schizophr Res (2007) 0.88